Joseph Fitzgerald Arboleda-Velasquez, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
CADASIL | 12 | 2022 | 88 | 3.060 |
Why?
|
Apolipoprotein E3 | 6 | 2024 | 107 | 1.950 |
Why?
|
Presenilin-1 | 8 | 2024 | 660 | 1.770 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 5 | 2021 | 351 | 1.570 |
Why?
|
Pericytes | 5 | 2017 | 293 | 1.430 |
Why?
|
Alzheimer Disease | 17 | 2024 | 8547 | 1.290 |
Why?
|
Receptors, Notch | 10 | 2020 | 743 | 1.040 |
Why?
|
Diabetic Retinopathy | 6 | 2020 | 1268 | 1.040 |
Why?
|
Retinal Neovascularization | 3 | 2017 | 273 | 0.980 |
Why?
|
Apolipoprotein E4 | 4 | 2024 | 707 | 0.890 |
Why?
|
Vitreoretinopathy, Proliferative | 2 | 2020 | 68 | 0.840 |
Why?
|
Retina | 5 | 2020 | 2635 | 0.780 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2020 | 730 | 0.510 |
Why?
|
Cell Separation | 4 | 2017 | 1720 | 0.510 |
Why?
|
Colombia | 7 | 2024 | 276 | 0.480 |
Why?
|
Retinal Vessels | 2 | 2016 | 836 | 0.420 |
Why?
|
Apolipoprotein E2 | 3 | 2024 | 135 | 0.390 |
Why?
|
Blindness | 1 | 2015 | 582 | 0.370 |
Why?
|
Neurodegenerative Diseases | 1 | 2019 | 1084 | 0.350 |
Why?
|
Arterioles | 1 | 2011 | 250 | 0.350 |
Why?
|
Neurofilament Proteins | 2 | 2024 | 333 | 0.350 |
Why?
|
Antibodies | 1 | 2017 | 2421 | 0.330 |
Why?
|
Endothelial Cells | 2 | 2020 | 3539 | 0.310 |
Why?
|
Transfection | 2 | 2016 | 5781 | 0.310 |
Why?
|
Retinal Artery | 2 | 2021 | 109 | 0.300 |
Why?
|
Fucose | 2 | 2005 | 122 | 0.300 |
Why?
|
Proto-Oncogene Proteins | 2 | 2014 | 4490 | 0.300 |
Why?
|
Signal Transduction | 11 | 2023 | 23376 | 0.290 |
Why?
|
Choroidal Neovascularization | 2 | 2020 | 357 | 0.280 |
Why?
|
Brain | 14 | 2024 | 26951 | 0.280 |
Why?
|
Homozygote | 3 | 2022 | 1788 | 0.280 |
Why?
|
Mutation | 14 | 2024 | 29932 | 0.270 |
Why?
|
Epiretinal Membrane | 2 | 2017 | 73 | 0.260 |
Why?
|
Age of Onset | 5 | 2024 | 3301 | 0.260 |
Why?
|
Stroke | 4 | 2019 | 9962 | 0.250 |
Why?
|
Heterozygote | 4 | 2024 | 2798 | 0.250 |
Why?
|
Cell Survival | 1 | 2014 | 5797 | 0.230 |
Why?
|
Cerebrovascular Disorders | 1 | 2011 | 1501 | 0.230 |
Why?
|
Disease Models, Animal | 10 | 2021 | 18137 | 0.230 |
Why?
|
N-Acetylglucosaminyltransferases | 1 | 2005 | 167 | 0.230 |
Why?
|
Muscle, Smooth, Vascular | 3 | 2017 | 1485 | 0.220 |
Why?
|
Amyloid | 2 | 2019 | 842 | 0.220 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2803 | 0.220 |
Why?
|
Heparan Sulfate Proteoglycans | 1 | 2023 | 112 | 0.220 |
Why?
|
Animals | 20 | 2023 | 167963 | 0.210 |
Why?
|
Dementia, Multi-Infarct | 1 | 2002 | 10 | 0.210 |
Why?
|
Gene Expression Regulation | 2 | 2020 | 11903 | 0.210 |
Why?
|
Endothelium, Vascular | 1 | 2015 | 4433 | 0.210 |
Why?
|
Dementia, Vascular | 2 | 2021 | 123 | 0.210 |
Why?
|
Genes, Dominant | 1 | 2024 | 863 | 0.190 |
Why?
|
Alleles | 2 | 2020 | 6898 | 0.190 |
Why?
|
Presenilins | 1 | 2021 | 53 | 0.190 |
Why?
|
Furin | 1 | 2021 | 46 | 0.190 |
Why?
|
Apolipoproteins E | 2 | 2023 | 1436 | 0.190 |
Why?
|
Retinal Vein | 1 | 2021 | 47 | 0.180 |
Why?
|
Emulsions | 1 | 2020 | 152 | 0.180 |
Why?
|
Tauopathies | 1 | 2023 | 317 | 0.170 |
Why?
|
Cattle | 2 | 2016 | 3847 | 0.160 |
Why?
|
Magnetic Resonance Imaging | 9 | 2021 | 36290 | 0.160 |
Why?
|
Receptors, Cell Surface | 2 | 2005 | 2825 | 0.160 |
Why?
|
Mice | 13 | 2023 | 81208 | 0.150 |
Why?
|
Wet Macular Degeneration | 1 | 2020 | 162 | 0.150 |
Why?
|
Leukoencephalopathies | 1 | 2021 | 249 | 0.150 |
Why?
|
Cell Proliferation | 4 | 2017 | 10446 | 0.140 |
Why?
|
Pulmonary Fibrosis | 1 | 2021 | 506 | 0.140 |
Why?
|
Humans | 38 | 2024 | 760621 | 0.140 |
Why?
|
Retinopathy of Prematurity | 1 | 2020 | 432 | 0.130 |
Why?
|
Family | 2 | 2024 | 3189 | 0.130 |
Why?
|
Endostatins | 1 | 2016 | 168 | 0.130 |
Why?
|
Drosophila Proteins | 1 | 2005 | 1699 | 0.130 |
Why?
|
Mice, Transgenic | 3 | 2017 | 9530 | 0.130 |
Why?
|
Male | 24 | 2024 | 359744 | 0.130 |
Why?
|
Small Molecule Libraries | 1 | 2020 | 734 | 0.120 |
Why?
|
Cells, Cultured | 5 | 2021 | 18957 | 0.120 |
Why?
|
Angiopoietin-1 | 1 | 2015 | 122 | 0.120 |
Why?
|
Executive Function | 2 | 2020 | 1374 | 0.120 |
Why?
|
Retinal Pigment Epithelium | 1 | 2017 | 301 | 0.120 |
Why?
|
Rabbits | 1 | 2020 | 4773 | 0.120 |
Why?
|
Cognition Disorders | 4 | 2021 | 3976 | 0.120 |
Why?
|
Immunologic Factors | 1 | 2023 | 1588 | 0.120 |
Why?
|
Brain Ischemia | 1 | 2008 | 3127 | 0.120 |
Why?
|
Comparative Genomic Hybridization | 1 | 2015 | 473 | 0.110 |
Why?
|
Genetic Predisposition to Disease | 5 | 2021 | 17790 | 0.110 |
Why?
|
Female | 21 | 2024 | 391270 | 0.110 |
Why?
|
MAP Kinase Signaling System | 1 | 2020 | 1484 | 0.110 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2015 | 550 | 0.110 |
Why?
|
Amyloid beta-Peptides | 4 | 2022 | 3832 | 0.110 |
Why?
|
Evoked Potentials | 1 | 2018 | 1036 | 0.100 |
Why?
|
Positron-Emission Tomography | 3 | 2024 | 6465 | 0.100 |
Why?
|
Adult | 14 | 2024 | 219994 | 0.100 |
Why?
|
Immunohistochemistry | 2 | 2017 | 11071 | 0.100 |
Why?
|
Phosphorylation | 1 | 2023 | 8313 | 0.100 |
Why?
|
Coculture Techniques | 2 | 2014 | 1342 | 0.100 |
Why?
|
Recombinant Fusion Proteins | 1 | 2020 | 3735 | 0.100 |
Why?
|
Liposomes | 1 | 2016 | 777 | 0.100 |
Why?
|
Aged | 9 | 2024 | 169152 | 0.100 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2020 | 4357 | 0.100 |
Why?
|
Pedigree | 1 | 2019 | 4578 | 0.100 |
Why?
|
Cell Culture Techniques | 2 | 2017 | 1664 | 0.100 |
Why?
|
tau Proteins | 2 | 2022 | 2085 | 0.100 |
Why?
|
Serine Endopeptidases | 1 | 2016 | 1021 | 0.090 |
Why?
|
Neuropsychological Tests | 5 | 2024 | 7021 | 0.090 |
Why?
|
Angiogenesis Inhibitors | 1 | 2020 | 2049 | 0.090 |
Why?
|
Plasmids | 1 | 2016 | 2275 | 0.090 |
Why?
|
Methotrexate | 1 | 2017 | 1719 | 0.090 |
Why?
|
Green Fluorescent Proteins | 1 | 2016 | 2057 | 0.090 |
Why?
|
Middle Aged | 13 | 2024 | 220352 | 0.080 |
Why?
|
Glucose | 2 | 2020 | 4351 | 0.080 |
Why?
|
Phenotype | 5 | 2021 | 16546 | 0.080 |
Why?
|
Memory | 1 | 2018 | 2179 | 0.080 |
Why?
|
Cell Movement | 2 | 2017 | 5206 | 0.080 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15289 | 0.080 |
Why?
|
Mice, Knockout | 2 | 2017 | 14372 | 0.080 |
Why?
|
Models, Animal | 1 | 2014 | 2117 | 0.070 |
Why?
|
Actins | 1 | 2015 | 2049 | 0.070 |
Why?
|
Mice, Inbred C57BL | 4 | 2020 | 22023 | 0.070 |
Why?
|
Transgenes | 1 | 2011 | 1006 | 0.070 |
Why?
|
Tomography, Optical Coherence | 1 | 2021 | 2884 | 0.070 |
Why?
|
COS Cells | 2 | 2005 | 1129 | 0.070 |
Why?
|
Early Diagnosis | 2 | 2021 | 1180 | 0.060 |
Why?
|
Oxygen | 1 | 2017 | 4193 | 0.060 |
Why?
|
Cognition | 4 | 2024 | 6957 | 0.060 |
Why?
|
Polymerase Chain Reaction | 1 | 2014 | 6068 | 0.060 |
Why?
|
Regional Blood Flow | 1 | 2008 | 1490 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4166 | 0.060 |
Why?
|
Genotype | 3 | 2024 | 12960 | 0.060 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2008 | 686 | 0.060 |
Why?
|
Mesenchymal Stem Cells | 1 | 2014 | 1634 | 0.060 |
Why?
|
Dimerization | 1 | 2005 | 891 | 0.050 |
Why?
|
Arteries | 1 | 2008 | 1126 | 0.050 |
Why?
|
Cross-Sectional Studies | 5 | 2024 | 25942 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2015 | 5125 | 0.050 |
Why?
|
Disease Progression | 2 | 2021 | 13502 | 0.050 |
Why?
|
Proteomics | 1 | 2016 | 3817 | 0.050 |
Why?
|
Lung | 1 | 2021 | 9994 | 0.050 |
Why?
|
CHO Cells | 1 | 2005 | 1389 | 0.050 |
Why?
|
Ischemia | 1 | 2011 | 1893 | 0.050 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2017 | 3455 | 0.050 |
Why?
|
Glycosylation | 1 | 2005 | 1096 | 0.050 |
Why?
|
RNA, Messenger | 1 | 2017 | 12766 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2011 | 2566 | 0.050 |
Why?
|
Cricetinae | 1 | 2005 | 2427 | 0.050 |
Why?
|
Apolipoproteins | 1 | 2023 | 320 | 0.050 |
Why?
|
Disease Susceptibility | 1 | 2008 | 1791 | 0.050 |
Why?
|
Aorta | 1 | 2008 | 2039 | 0.040 |
Why?
|
Bleomycin | 1 | 2021 | 495 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2007 | 1652 | 0.040 |
Why?
|
Intermediate Filaments | 1 | 2020 | 172 | 0.040 |
Why?
|
Genetic Association Studies | 2 | 2020 | 2717 | 0.040 |
Why?
|
Fibrinogen | 1 | 2022 | 886 | 0.040 |
Why?
|
Arginine | 1 | 2002 | 934 | 0.040 |
Why?
|
Retrospective Studies | 2 | 2024 | 80372 | 0.040 |
Why?
|
Photography | 1 | 2021 | 530 | 0.040 |
Why?
|
Cysteine | 1 | 2002 | 895 | 0.040 |
Why?
|
Flow Cytometry | 1 | 2008 | 5870 | 0.040 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2020 | 666 | 0.040 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2017 | 426 | 0.030 |
Why?
|
Carbolines | 1 | 2018 | 288 | 0.030 |
Why?
|
Preventive Health Services | 1 | 2021 | 570 | 0.030 |
Why?
|
Educational Status | 1 | 2023 | 2515 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2020 | 58995 | 0.030 |
Why?
|
Probability | 1 | 2020 | 2475 | 0.030 |
Why?
|
Risk Reduction Behavior | 1 | 2021 | 1109 | 0.030 |
Why?
|
Multiple Sclerosis | 1 | 2009 | 3204 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2002 | 4107 | 0.030 |
Why?
|
Cohort Studies | 3 | 2021 | 41335 | 0.030 |
Why?
|
Extracellular Matrix Proteins | 1 | 2017 | 829 | 0.030 |
Why?
|
Retinal Detachment | 1 | 2017 | 427 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2017 | 12293 | 0.030 |
Why?
|
Aniline Compounds | 1 | 2018 | 1069 | 0.030 |
Why?
|
Macrophages | 1 | 2007 | 5745 | 0.030 |
Why?
|
Up-Regulation | 1 | 2020 | 4122 | 0.020 |
Why?
|
Child | 4 | 2021 | 79806 | 0.020 |
Why?
|
Capillaries | 1 | 2014 | 744 | 0.020 |
Why?
|
Diffusion Tensor Imaging | 1 | 2021 | 2385 | 0.020 |
Why?
|
Thiazoles | 1 | 2018 | 1511 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2023 | 4407 | 0.020 |
Why?
|
Organ Size | 1 | 2015 | 2254 | 0.020 |
Why?
|
Retinal Degeneration | 1 | 2014 | 412 | 0.020 |
Why?
|
Microvessels | 1 | 2014 | 572 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2020 | 3484 | 0.020 |
Why?
|
Brain Diseases, Metabolic, Inborn | 1 | 2009 | 45 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2021 | 3663 | 0.020 |
Why?
|
Vasculitis, Central Nervous System | 1 | 2009 | 45 | 0.020 |
Why?
|
Protein Structure, Tertiary | 2 | 2006 | 3800 | 0.020 |
Why?
|
Attention | 1 | 2018 | 2387 | 0.020 |
Why?
|
Paresis | 1 | 2009 | 177 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9280 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10547 | 0.020 |
Why?
|
Inflammation | 1 | 2007 | 10756 | 0.020 |
Why?
|
Aphasia | 1 | 2009 | 192 | 0.020 |
Why?
|
Adolescent | 3 | 2021 | 87810 | 0.020 |
Why?
|
Basal Ganglia | 1 | 2009 | 552 | 0.020 |
Why?
|
Transcription Factors | 1 | 2005 | 12103 | 0.020 |
Why?
|
Mitochondrial Diseases | 1 | 2009 | 340 | 0.020 |
Why?
|
Chromatography, Gel | 1 | 2005 | 645 | 0.010 |
Why?
|
Corpus Callosum | 1 | 2009 | 749 | 0.010 |
Why?
|
Macrophage Activation | 1 | 2007 | 554 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14495 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 22053 | 0.010 |
Why?
|
Epidermal Growth Factor | 1 | 2005 | 695 | 0.010 |
Why?
|
Calcium-Binding Proteins | 1 | 2007 | 1067 | 0.010 |
Why?
|
Receptor, Notch1 | 1 | 2005 | 495 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2005 | 1693 | 0.010 |
Why?
|
Apoptosis | 1 | 2017 | 9501 | 0.010 |
Why?
|
Age Factors | 1 | 2018 | 18416 | 0.010 |
Why?
|
Models, Biological | 1 | 2017 | 9467 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2020 | 15789 | 0.010 |
Why?
|
Brain Mapping | 1 | 2015 | 6568 | 0.010 |
Why?
|
Blood Vessels | 1 | 2006 | 1112 | 0.010 |
Why?
|
Ligands | 1 | 2005 | 3276 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2007 | 2895 | 0.010 |
Why?
|
Binding Sites | 1 | 2005 | 6048 | 0.010 |
Why?
|
Migraine Disorders | 1 | 2009 | 1693 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 54303 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 65017 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 12965 | 0.010 |
Why?
|
Risk Factors | 1 | 2021 | 74359 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2007 | 7593 | 0.010 |
Why?
|
Atherosclerosis | 1 | 2007 | 3517 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2005 | 7850 | 0.000 |
Why?
|
Time Factors | 1 | 2005 | 40165 | 0.000 |
Why?
|